APRIL/TNFSF13 Antibodies
We offer APRIL/TNFSF13 Antibodies for use in common research applications: ELISA, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunoprecipitation, Intracellular Staining by Flow Cytometry, Neutralization, Sandwich ELISA, Western Blot. Each APRIL/TNFSF13 Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our APRIL/TNFSF13 Antibodies can be used in a variety of model species: Human, Mouse. Use the list below to choose the APRIL/TNFSF13 Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our APRIL/TNFSF13 polyclonal antibodies and browse our APRIL/TNFSF13 monoclonal antibody catalog.
Alternate Names for APRIL/TNFSF13 Antibodies
anti-APRIL/TNFSF13 antibody, anti-TNFSF13 antibody, anti-A proliferation-inducing ligand antibody, anti-APRILFLJ57090 antibody, anti-CD256 antibody, anti-CD256 antigen antibody, anti-TALL-2 antibody, anti-TALL2 antibody, anti-TNF- and APOL-related leukocyte expressed ligand 2 antibody, anti-TNF-related death ligand 1 antibody, anti-TRDL-1 antibody, anti-tumor necrosis factor (ligand) superfamily, member 13 antibody, anti-tumor necrosis factor ligand superfamily member 13 antibody, anti-tumor necrosis factor-like protein ZTNF2 antibody, anti-tumor necrosis factor-related death ligand-1 antibody, anti-ZTNF2 antibody
15 Results for "april-tnfsf13" in Primary Antibodies
![Western Blot: APRIL/TNFSF13 Antibody (Aprily-8) [NBP1-97587] - Total cell extracts from HEK 293 cells transfected with the indicated expression vector. Aprily-8 reacts specifically with human APRIL.Method: 10ug of protein was applied to the gel. Revealed with Aprily-8 (1ug/ml) and HRP-coupled anti-mouse secondary antibody (1:4000).Note: The human APRIL construct used in this experiment is an uncleavable fusion protein between human BAFF (aa 1-132) and human APRIL (aa 93-233).](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Aprily-8-Western-Blot-NBP1-97587-img0006.jpg "Western Blot: APRIL/TNFSF13 Antibody (Aprily-8) [NBP1-97587] - Total cell extracts from HEK 293 cells transfected with the indicated expression vector. Aprily-8 reacts specifically with human APRIL.Method: 10ug of protein was applied to the gel. Revealed with Aprily-8 (1ug/ml) and HRP-coupled anti-mouse secondary antibody (1:4000).Note: The human APRIL construct used in this experiment is an uncleavable fusion protein between human BAFF (aa 1-132) and human APRIL (aa 93-233).")
![Immunohistochemistry-Paraffin: APRIL/TNFSF13 Antibody (Aprily-8) [NBP1-97587] - Immunostaining of HEK 293 cells transfected with a human APRIL expression plasmid (left panels), or mock transfected (right panel) by Aprily-8.](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Aprily-8-Immunohistochemistry-Paraffin-NBP1-97587-img0005.jpg)
![Flow Cytometry: APRIL/TNFSF13 Antibody (Aprily-8) [NBP1-97587] - Analysis of cells with MAb to APRIL (Aprily-8).Method: HEK 293 cells were mock transfected or transfected with an expression plasmid coding for a non-cleavable human APRIL. Cells (5x10^5) were incubated on ice for 30 min. in 50ul FACS buffer (PBS, 5% fetal calf serum, 0.02% azide) containing 10ug/ml of Aprily-8 antibody. After washing in FACS buffer, FITC-conjugated antibody to mouse IgG was added. Cells were incubated on ice for 30 min., washed and analyzed by flow cytometry.](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Aprily-8-Flow-Cytometry-NBP1-97587-img0004.jpg)
![Western Blot: APRIL/TNFSF13 Antibody (Aprily-5) [NBP1-97599] - Breast cancer cells induce secretion of APRIL from neutrophils. APRIL stalk is clearly detectable in neutrophils but not in breast cancer cells. On the left panel, lysates of MCF7, T47D, Hs578T, and SKBR3 cells (60 ug each), as well as neutrophils (5 ug) were subjected to SDS-PAGE and western blotting using APRIL stalk antibody. On the right panel, neutrophils and T47D cells [non-transfected and transfected with pCR3 (T47D-pCR3) or pCR3-soluble APRIL (T47D-pCR3-sAPRIL)] were immunoblotted using Aprily-5 (Novus Biologicals: NBP1-97599; top panel) and reblotted using April ED (middle panel) antibodies. Aprily-5 detects soluble APRIL. The bottom panel shows Ponceau S staining of the membranes Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41389-018-0058-2) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Aprily-5-Western-Blot-NBP1-97599-img0002.jpg "Western Blot: APRIL/TNFSF13 Antibody (Aprily-5) [NBP1-97599] - Breast cancer cells induce secretion of APRIL from neutrophils. APRIL stalk is clearly detectable in neutrophils but not in breast cancer cells. On the left panel, lysates of MCF7, T47D, Hs578T, and SKBR3 cells (60 ug each), as well as neutrophils (5 ug) were subjected to SDS-PAGE and western blotting using APRIL stalk antibody. On the right panel, neutrophils and T47D cells [non-transfected and transfected with pCR3 (T47D-pCR3) or pCR3-soluble APRIL (T47D-pCR3-sAPRIL)] were immunoblotted using Aprily-5 (Novus Biologicals: NBP1-97599; top panel) and reblotted using April ED (middle panel) antibodies. Aprily-5 detects soluble APRIL. The bottom panel shows Ponceau S staining of the membranes Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41389-018-0058-2) licensed under a CC-BY license.")
![Western Blot: APRIL/TNFSF13 Antibody (Aprily-5) [NBP1-97599] - Detection of endogenous human APRIL with MAb to APRIL (human) (Aprily-5). Method: Cell lysate (A) or cell supernatant (B) were run on an SDS-PAGE gel and analyzed with 2ug/ml Aprily-5 by Western blot. Dendritic cells (1), NIH3T3 (2) and NIH3T3 expressing human APRIL (3).](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Aprily-5-Western-Blot-NBP1-97599-img0001.jpg)
![Western Blot: APRIL/TNFSF13 Antibody [NBP1-76767] - Jurkat cells with TNFSF13 antibody at 1 ug/ml (A), 2 ug/ml (B), and 4 ug/ml (C).](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Western-Blot-NBP1-76767-img0004.jpg "Western Blot: APRIL/TNFSF13 Antibody [NBP1-76767] - Jurkat cells with TNFSF13 antibody at 1 ug/ml (A), 2 ug/ml (B), and 4 ug/ml (C).")
![Immunohistochemistry: APRIL/TNFSF13 Antibody - BSA Free [NBP1-76767] - Immunohistochemistry of APRIL/TNFSF13 in human prostate tissue with APRIL/TNFSF13 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76767_rabbit-polyclonal-april-tnfsf13-antibody-271120242016937.jpg)
![Western Blot: APRIL/TNFSF13 Antibody (SR1578) [NBP3-22069] - Western blot analysis using NBP3-22069 in Jurkat cell lysate.](http://images.novusbio.com/fullsize/nbp3-22069_rabbit-april-tnfsf13-mab-sr1578-5720231558489.jpg "Western Blot: APRIL/TNFSF13 Antibody (SR1578) [NBP3-22069] - Western blot analysis using NBP3-22069 in Jurkat cell lysate.")